Actym Therapeutics
PrivateLast Round
Series A
Extension
Oct 18, 2023
Total Funding Raised
$70.74M
Momentum Score
25 /100
Company Overview
Actym Therapeutics is a biotechnology company that develops innovative immunotherapy platforms aimed at overcoming the challenging tumor immune microenvironment to provide lasting benefits for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Actym Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Actym Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 18, 2023 | ||||
| Series A | Jun 28, 2023 | ||||
| Series A | Apr 27, 2020 |
Key People
Founding team and executive leadership
Actym Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Series A Extension, Series A |
| Boehringer Ingelheim Venture Fund | Series A |
| Boehringer Ingelheim Venture Fund | Series A Extension, Series A |
| Panacea Venture Healthcare | Series A |
| Korea Investment Partners | Series A |
| Korea Investment Partners | Series A |
| Illumina Ventures | Series A, Series A Extension |
Actym Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Actym Therapeutics's valuation, stock price, and market status.
